Sana Biotechnology (SANA) Depreciation and Depletion (2020 - 2026)

Sana Biotechnology has disclosed Depreciation and Depletion across 7 years of filings, most recently posting $2.4 million for Q1 2026.

• Depreciation and Depletion for Q1 2026 came in at $2.4 million, down 33.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.6 million (down 24.73% YoY), and the FY2025 annual result was $12.8 million, down 17.42% from the prior year.
• Depreciation and Depletion came in at $2.4 million for Q1 2026 at Sana Biotechnology, down from $3.1 million in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $4.5 million in Q2 2023 to a low of $2.4 million in Q1 2026.
• The 5-year median for Depreciation and Depletion is $3.8 million (2022), against an average of $3.8 million.
• Across the five-year window, Depreciation and Depletion soared 60.21% in 2022 and plunged 33.58% in 2026, its largest moves.
• Sana Biotechnology's Depreciation and Depletion stood at $4.2 million in 2022, then changed by 0.0% to $4.2 million in 2023, then dropped by 9.52% to $3.8 million in 2024, then retreated by 18.42% to $3.1 million in 2025, then slipped by 22.87% to $2.4 million in 2026.
• The last three Depreciation and Depletion figures came in at $2.4 million (Q1 2026), $3.1 million (Q4 2025), and $3.2 million (Q3 2025), per Business Quant data.